| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |